Biodexa Pharmaceuticals Plc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BDRX Nasdaq 2834 www.biodexapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biodexa Pharmaceuticals Plc

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - Aug 7th, 2026 9:14 am
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading - Aug 6th, 2026 9:18 am
European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading - Aug 5th, 2026 9:12 am
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading - Aug 3rd, 2026 9:05 am
Result of General Meeting - Jul 29th, 2026 2:30 pm
European Equities Traded in US as ADRs Ease in Wednesday Trading - Jul 29th, 2026 9:05 am
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France - Jul 29th, 2026 6:30 am
European Equities Traded in US as ADRs Ease in Tuesday Trading - Jul 28th, 2026 9:04 am
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - Jul 22nd, 2026 9:10 am
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading - Jul 20th, 2026 9:13 am
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading - Jul 2nd, 2026 9:13 am
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading - Jul 1st, 2026 9:12 am
Result of Annual General Meeting - Jun 30th, 2026 2:30 pm
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - Jun 30th, 2026 9:11 am
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants - Jun 30th, 2026 6:00 am
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - Jun 29th, 2026 9:11 am
BDRX: Expanding Phase 3 SERENTA Trial into Canada; 73 Patients Enrolled Thus Far - Jun 29th, 2026 8:17 am
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress - Jun 29th, 2026 6:30 am
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - Jun 24th, 2026 9:15 am
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading - Jun 23rd, 2026 9:10 am